Century Therapeutics appoints Joseph Truitt to board
Century Therapeutics appointed Joseph Truitt to its board as a Class I director, effective September 9, 2026. He was also named to the Compensation Committee.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
Century Therapeutics appoints Joseph Truitt to its board
Century Therapeutics, Inc. announced the appointment of Joseph Truitt to its board of directors. The company said it develops iPSC-derived cell therapies for autoimmune diseases including type 1 diabetes and cancer.